Expression profiles and functional associations of endogenous androgen receptor and caveolin-1 in prostate cancer cell lines

Prostate

Volumn 74, Issue 5, 2014, Pages 478-487

  Bennett, Nigel C ^a   Hooper, John D ^a   Johnson, David W ^b   Gobe, Glenda C ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

androgen deprivation; androgen dependent; androgen sensitive; co activator; prostate; prostate cancer

Indexed keywords

ANDROGEN DEPRIVATION; ANDROGEN-DEPENDENT; ANDROGEN-SENSITIVE; CO-ACTIVATOR; PROSTATE; PROSTATE CANCER;

CAVEOLIN 1; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; PROSTATE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC;

EID: 84894249509     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22767     Document Type: Article

References (41)

1. Bennett N, Hooper JD, Lee CS, Gobe GC,. Androgen receptor and caveolin-1 in prostate cancer. IUBMB Life 2009; 61: 961-970.
2. Hobisch A, Culig Z, Radmayr C, Bartsch G, Klocker H, Hittmair A,. Distant metastases from prostatic carcinoma express androgen receptor protein. Cancer Res 1995; 55: 3068-3072.
3. Kim D, Gregory CW, French FS, Smith GJ, Mohler JL,. Androgen receptor expression and cellular proliferation during transition from androgen-dependent to recurrent growth after castration in the CWR22 prostate cancer xenograft. Am J Pathol 2002; 160: 219-226. (Pubitemid 34052282)
4. Nguyen HC, Xie W, Yang M, Hsieh CL, Drouin S, Lee GS, Kantoff PW,. Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer. Prostate 2013; 73: 346-354.
5. van der Kwast TH, Schalken J, Ruizeveld de Winter JA, van Vroonhoven CC, Mulder E, Boersma W, Trapman J,. Androgen receptors in endocrine-therapy- resistant human prostate cancer. Int J Cancer 1991; 48: 189-193.
6. Lu ML, Schneider MC, Zheng Y, Zhang X, Richie JP,. Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation. J Biol Chem 2001; 276: 13442-13451.
7. Li L, Yang G, Ebara S, Satoh T, Nasu Y, Timme TL, Ren C, Wang J, Tahir SA, Thompson TC,. Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells. Cancer Res 2001; 61: 4386-4392. (Pubitemid 32685764)
8. Yang G, Truong LD, Wheeler TM, Thompson TC,. Caveolin-1 expression in clinically confined human prostate cancer: A novel prognostic marker. Cancer Res 1999; 59: 5719-5723.
9. Parton RG, Simons K,. The multiple faces of caveolae. Nat Rev Mol Cell Biol 2007; 8: 185-194.
10. Hill MM, Bastiani M, Luetterforst R, Kirkham M, Kirkham A, Nixon SJ, Walser P, Abankwa D, Oorschot VM, Martin S, Hancock JF, Parton RG,. PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function. Cell 2008; 132: 113-124.
11. Orlichenko L, Huang B, Krueger E, McNiven MA,. Epithelial growth factor-induced phosphorylation of caveolin 1 at tyrosine 14 stimulates caveolae formation in epithelial cells. J Biol Chem 2006; 281: 4570-4579. (Pubitemid 43847715)
12. Parton RG, Hanzal-Bayer M, Hancock JF,. Biogenesis of caveolae: A structural model for caveolin-induced domain formation. J Cell Sci 2006; 119: 787-796.
13. Krajewska WM, Maslowska I,. Caveolins: Structure and function in signal transduction. Cell Mol Biol Lett 2004; 9: 195-220. (Pubitemid 38902217)
14. Bryant KG, Camacho J, Jasmin JF, Wang C, Addya S, Casimiro MC, Fortina P, Balasubramaniam S, Knudsen KE, Schwarting R, Lisanti MP, Mercier I,. Caveolin-1 overexpression enhances androgen-dependent growth and proliferation in the mouse prostate. Int J Biochem Cell Biol 2011; 43: 1318-1329.
15. van Steenbrugge GJ, van Uffelen CJ, Bolt J, Schroder FH,. The human prostatic cancer cell line LNCaP and its derived sublines: An in vitro model for the study of androgen sensitivity. J Steroid Biochem Mol Biol 1991; 40: 207-214.
16. Vajda A, Marignol L, Barrett C, Madden SF, Lynch TH, Hollywood D, Perry AS,. Gene expression analysis in prostate cancer: The importance of the endogenous control. Prostate 2013; 73: 382-390.
17. Yu N, Kozlowski JM, Park II, Chen L, Zhang Q, Xu D, Doll JA, Crawford SE, Brendler CB, Lee C,. Overexpression of transforming growth factor beta1 in malignant prostate cells is partly caused by a runaway of TGF-beta1 auto-induction mediated through a defective recruitment of protein phosphatase 2A by TGF-beta type I receptor. Urology 2010; 76: 1519 e8-1519 e13.
18. Bennett NC, Hooper JD, Lambie D, Lee CS, Yang T, Vesey DA, Samaratunga H, Johnson DW, Gobe GC,. Evidence for steroidogenic potential in human prostate cell lines and tissues. Am J Pathol 2012; 181: 1078-1087.
19. Song KS, Li S, Okamoto T, Quilliam LA, Sargiacomo M, Lisanti MP,. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J Biol Chem 1996; 271: 9690-9697.
20. Srivastava J, Barber D,. Actin co-sedimentation assay; for the analysis of protein binding to F-actin. J Vis Exp 2008; 28pii: 690.
21. Gould ML, Williams G, Nicholson HD,. Changes in caveolae, caveolin, and polymerase 1 and transcript release factor (PTRF) expression in prostate cancer progression. Prostate 2010; 70: 1609-1621.
22. Hartel A, Didier A, Pfaffl MW, Meyer HH,. Characterisation of gene expression patterns in 22RV1 cells for determination of environmental androgenic/antiandrogenic compounds. J Steroid Biochem Mol Biol 2003; 84: 231-238. (Pubitemid 36519202)
23. Mitchell SH, Murtha PE, Zhang S, Zhu W, Young CY,. An androgen response element mediates LNCaP cell dependent androgen induction of the hK2 gene. Mol Cell Endocrinol 2000; 168: 89-99.
24. Trapman J, Klaassen P, Kuiper GG, van der Korput JA, Faber PW, van Rooij HC, Geurts van Kessel A, Voorhorst MM, Mulder E, Brinkmann AO,. Cloning, structure and expression of a cDNA encoding the human androgen receptor. Biochem Biophys Res Commun 1988; 153: 241-248.
25. Edelstein RA, Carr MC, Caesar R, Young M, Atala A, Freeman MR,. Detection of human androgen receptor mRNA expression abnormalities by competitive PCR. DNA Cell Biol 1994; 13: 265-273. (Pubitemid 24296988)
26. Song CH, Yang SH, Park E, Cho SH, Gong EY, Khadka DB, Cho WJ, Lee K,. Structure-based virtual screening and identification of a novel androgen receptor antagonist. J Biol Chem 2012; 287: 30769-30780.
27. Nakhla AM, Rosner W,. Characterization of ALVA-41 cells: A new human prostatic cancer cell line. Steroids 1994; 59: 586-589. (Pubitemid 24333270)
28. Bello D, Webber MM, Kleinman HK, Wartinger DD, Rhim JS,. Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. Carcinogenesis 1997; 18: 1215-1223. (Pubitemid 28132513)
29. Bartz R, Zhou J, Hsieh JT, Ying Y, Li W, Liu P,. Caveolin-1 secreting LNCaP cells induce tumor growth of caveolin-1 negative LNCaP cells in vivo. Int J Cancer 2008; 122: 520-525. (Pubitemid 350308942)
30. Chinnaiyan P, Varambally S, Tomlins SA, Ray S, Huang S, Chinnaiyan AM, Harari PM,. Enhancing the antitumor activity of ErbB blockade with histone deacetylase (HDAC) inhibition. Int J Cancer 2006; 118: 1041-1050. (Pubitemid 43157683)
31. Tahir SA, Yang G, Ebara S, Timme TL, Satoh T, Li L, Goltsov A, Ittmann M, Morrisett JD, Thompson TC,. Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer. Cancer Res 2001; 61: 3882-3885. (Pubitemid 32720945)
32. Gumulec J, Sochor J, Hlavna M, Sztalmachova M, Krizkova S, Babula P, Hrabec R, Rovny A, Adam V, Eckschlager T, Kizek R, Masarik M,. Caveolin-1 as a potential high-risk prostate cancer biomarker. Oncol Rep 2012; 27: 831-841.
33. Okamoto T, Schlegel A, Scherer PE, Lisanti MP,. Caveolins, a family of scaffolding proteins for organizing preassembled signaling complexes at the plasma membrane. J Biol Chem 1998; 273: 5419-5422. (Pubitemid 28123999)
34. Razani B, Woodman SE, Lisanti MP,. Caveolae: From cell biology to animal physiology. Pharmacol Rev 2002; 54: 431-467.
35. Byrne DP, Dart C, Rigden DJ,. Evaluating caveolin interactions: Do proteins interact with the caveolin scaffolding domain through a widespread aromatic residue-rich motif ? PLoS ONE 2012; 7: e44879.
36. Demova H, Komers R,. Determination of caveolin-1 in renal caveolar and non-caveolar fractions in experimental type 1 diabetes. Physiol Res 2009; 58: 563-568.
37. Lajoie P, Kojic LD, Nim S, Li L, Dennis JW, Nabi IR,. Caveolin-1 regulation of dynamin-dependent, raft-mediated endocytosis of cholera toxin b-subunit occurs independently of caveolae. J Cell Mol Med 2009; 13: 3218-3225.
38. Lajoie P, Nabi IR,. Regulation of raft-dependent endocytosis. J Cell Mol Med 2007; 11: 644-653. (Pubitemid 47313313)
39. Freeman MR, Cinar B, Lu ML,. Membrane rafts as potential sites of nongenomic hormonal signaling in prostate cancer. Trends Endocrinol Metab 2005; 16: 273-279. (Pubitemid 41058759)
40. Freeman MR, Yang W, Di Vizio D,. Caveolin-1 and prostate cancer progression. Adv Exp Med Biol 2012; 729: 95-110.
41. Bennett NC, Gardiner RA, Hooper JD, Johnson DW, Gobe GC,. Molecular cell biology of androgen receptor signalling. Int J Biochem Cell Biol 2010; 42: 813-827.